Home > All categories> Biochemicals and Pharmaceutical Chemicals> Pharmaceutical Impurities> Raltegravir potassium

Raltegravir potassium

Get Latest Price >

FOB Price contact us for price

Origin: China

Cas No: 871038-72-1

Specification: 99%min

Min order Quantity: 1 /kg

Supply Ability: 100 mt/month

Lead time: 7 days for OEM, 3 days for ready goods

Vendor:

Payment Terms:

Inquiry now

* Send an Inquiry to us

Add to wishlist

* Name your price
* Start order doesn't mean buying now

Products Specification
Product Description

Property

CAS No.: 871038-72-1 Formula: C20H20FKN6O5 Molecular Weight: 482.50700

Description

Raltegravir (RAL, Isentress, formerly MK-0518) is an antiretroviral drug produced by Merck & Co., used to treat HIV infection. It received approval by the U.S. Food and Drug Administration (FDA) on 12 October 2007, the first of a new class of HIV drugs, the integrase inhibitors, to receive such approval.
In December 2011, it received FDA approval for pediatric use in patients ages 2–18, taken in pill form orally twice a day by prescription with two other antiretroviral medications to form the cocktail (most anti-HIV drugs regimens for adults and children use these cocktails). Raltegravir is available in chewable form, but because the two tablet formulations are not interchangeable, the chewable pills are only approved for use in children two to 11. Older adolescents will use the adult formulation.

Basic Info

Chemical Name	Raltegravir potassium
Synonyms	N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide Potassium Salt; Raltegravir (potassium salt); MK 0518; Raltegravir K; Raltegravir(MK-0518); Raltegravirpotassium;
CAS No.	871038-72-1
Molecular Formula	C20H20FKN6O5
Molecular Weight	482.50700
PSA	155.07000
LogP	2.13150